Pharma 101 - Pharmaceutical Fraud
Aventis Aware of Fraudulent Data Regarding Ketek Says CRO Employee
A former staff member of the Pharmaceutical Product Development (PPD) has claimed that Aventis and PPD - the contract research organization (CRO) hired by Aventis- both knew of fraudulent data in a postmarketing trial for the antibiotic drug during a testimony before a US Congressional subcommittee last week.
The postmarketing study was carried out between November 2001 and March 2002 on behalf of Aventis by PPD, after the FDA required more safety information on Ketek following concerns that it could cause liver problems.
The study was allegedly riddled with fraud, including unscrupulous patient recruitment by some of the enrolling doctors and significant under reporting of adverse events.
To read more about CRO fraud and how it can result in a violation of the False Claims Act, click here.
No Tags| Posted By Kenneth Nolan | |
| Category Legal | Posted February 22nd, 2007 |
| Bookmark | |
Leave a Reply
Regulatory Documents (PDF)
- OIG Compliance Program Guidance for Pharmaceutical Manufacturers
- Medicaid Rebate Applicability of Physician Administered Drugs
Nolan Law Firm Articles
- Pages
- Categories
- Clinical Trials (2)
- Legal (36)
- Medicare (4)
- Off-Label (2)
- Pharmaceutical (2)
- Feeds
- Archives
Nolan & Auerbach, P.A. is a qui tam law firm whose practice is uniquely limited to healthcare fraud cases under the qui tam provisions of the False Claims Act. We know healthcare fraud because that's what we do! Toll free: 800-FRAUD 04
"The hiring of a lawyer is an important decision that should not be based
solely on advertisements. Before you decide, ask us to send you free written
information about our qualifications and experience."
Licensed in Florida
Located in Fort Lauderdale, Florida
Available for National Cases